Pathstone Holdings’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.3M Buy
36,497
+9,070
+33% +$769K 0.01% 847
2026
Q1
$2.29M Sell
27,427
-1,882
-6% -$154K 0.01% 959
2025
Q4
$2.68M Sell
29,309
-389
-1% -$37.2K 0.01% 881
2025
Q3
$2.81M Buy
29,698
+736
+3% +$69.3K 0.01% 839
2025
Q2
$3.03M Buy
28,962
+2,300
+9% +$218K 0.01% 762
2025
Q1
$2.36M Buy
26,662
+8,279
+45% +$849K 0.01% 889
2024
Q4
$1.76M Buy
18,383
+1,605
+10% +$150K 0.01% 1047
2024
Q3
$1.37M Sell
16,778
-5,460
-25% -$421K 0.01% 1197
2024
Q2
$1.92M Buy
22,238
+14,351
+182% +$1.16M 0.01% 939
2024
Q1
$644K Buy
7,887
+873
+12% +$68.2K ﹤0.01% 1552
2023
Q4
$465K Buy
+7,014
New +$486K ﹤0.01% 1552

Other funds holding HQY

Pathstone Holdings's HQY Position: Q2 2026 in Review

Pathstone Holdings increased its HealthEquity (HQY) stake by 33% in Q2 2026, buying an estimated $769K and bringing the position to 36,497 shares worth $3.3M. The position accounts for 0.01% of the portfolio, ranked #847.

Pathstone Holdings first reported a position in HQY in Q4 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Pathstone Holdings held 36,497 shares of HealthEquity worth $3.3M as of Q2 2026.
  • Pathstone Holdings bought 9,070 HealthEquity shares in Q2 2026, an estimated $769K.
  • HealthEquity made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #847 holding.
  • Pathstone Holdings first reported a position in HealthEquity in Q4 2023 and has held it in 11 quarters since.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.